Metropolitan Life Insurance CO Aerie Pharmaceuticals Inc Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jun 14, 2023
BUY
$6.37 - $15.23 $19,020 - $45,476
2,986 New
2,986 $45.2 Million
Q2 2022

Jun 20, 2023
BUY
$4.95 - $9.16 $14,780 - $27,351
2,986 New
2,986 $22,000
Q1 2022

Jun 20, 2023
BUY
$5.64 - $9.8 $16,841 - $29,262
2,986 New
2,986 $27,000
Q1 2022

Mar 30, 2023
SELL
$5.64 - $9.8 $49,400 - $85,838
-8,759 Reduced 74.58%
2,986 $27,000
Q1 2022

May 12, 2022
SELL
$5.64 - $9.8 $49,400 - $85,838
-8,759 Reduced 74.58%
2,986 $27,000
Q4 2021

Jun 21, 2023
BUY
$7.02 - $13.33 $82,449 - $156,560
11,745 New
11,745 $82,000
Q4 2021

Mar 30, 2023
SELL
$7.02 - $13.33 $259 - $493
-37 Reduced 0.31%
11,745 $82,000
Q4 2021

Feb 15, 2022
SELL
$7.02 - $13.33 $259 - $493
-37 Reduced 0.31%
11,745 $82,000
Q3 2021

Jun 21, 2023
BUY
$11.32 - $16.63 $133,372 - $195,934
11,782 New
11,782 $134,000
Q2 2021

Jun 21, 2023
BUY
$15.16 - $18.97 $178,615 - $223,504
11,782 New
11,782 $188,000
Q2 2021

Mar 30, 2023
BUY
$15.16 - $18.97 $10,793 - $13,506
712 Added 6.43%
11,782 $188,000
Q2 2021

Aug 16, 2021
BUY
$15.16 - $18.97 $178,448 - $223,295
11,771 Added 107009.09%
11,782 $189,000
Q1 2021

Jun 26, 2023
BUY
$13.12 - $20.9 $145,238 - $231,362
11,070 New
11,070 $198 Million
Q1 2021

Mar 30, 2023
SELL
$13.12 - $20.9 $14,969 - $23,846
-1,141 Reduced 9.34%
11,070 $197,000
Q1 2021

May 14, 2021
SELL
$13.12 - $20.9 $160,064 - $254,979
-12,200 Reduced 99.91%
11 $198,000
Q4 2020

Jun 22, 2023
BUY
$9.12 - $14.49 $111,364 - $176,937
12,211 New
12,211 $164,000
Q4 2020

Mar 30, 2023
SELL
$9.12 - $14.49 $7,286 - $11,577
-799 Reduced 6.14%
12,211 $164,000
Q4 2020

Feb 16, 2021
SELL
$9.12 - $14.49 $7,286 - $11,577
-799 Reduced 6.14%
12,211 $165,000
Q3 2020

Jun 26, 2023
BUY
$10.46 - $14.46 $136,084 - $188,124
13,010 New
13,010 $153,000
Q3 2020

Mar 30, 2023
SELL
$10.46 - $14.46 $11,024 - $15,240
-1,054 Reduced 7.49%
13,010 $153,000
Q3 2020

Nov 13, 2020
SELL
$10.46 - $14.46 $11,024 - $15,240
-1,054 Reduced 7.49%
13,010 $153,000
Q2 2020

Jun 26, 2023
BUY
$12.0 - $16.13 $168,768 - $226,852
14,064 New
14,064 $207,000
Q1 2020

Jul 12, 2023
BUY
$11.84 - $25.52 $166,517 - $358,913
14,064 New
14,064 $189,000
Q4 2019

Jul 12, 2023
BUY
$17.72 - $25.1 $249,214 - $353,006
14,064 New
14,064 $339,000
Q3 2019

Jul 12, 2023
BUY
$18.41 - $28.0 $258,918 - $393,792
14,064 New
14,064 $270,000
Q3 2019

Mar 30, 2023
BUY
$18.41 - $28.0 $45,804 - $69,664
2,488 Added 21.49%
14,064 $270,000
Q3 2019

Nov 14, 2019
BUY
$18.41 - $28.0 $45,804 - $69,664
2,488 Added 21.49%
14,064 $270,000
Q2 2019

Jul 12, 2023
BUY
$28.97 - $48.21 $350,768 - $583,726
12,108 New
12,108 $357,000
Q1 2019

Jul 13, 2023
BUY
$36.32 - $49.25 $420,440 - $570,118
11,576 New
11,576 $549,000
Q1 2019

Mar 30, 2023
BUY
$36.32 - $49.25 $420,440 - $570,118
11,576 New
11,576 $549,000
Q1 2019

May 16, 2019
SELL
$36.32 - $49.25 $27.6 Million - $37.4 Million
-758,707 Reduced 98.5%
11,576 $549,000
Q1 2019

May 15, 2019
BUY
$36.32 - $49.25 $27.6 Million - $37.4 Million
758,707 Added 6554.14%
770,283 $90.8 Million
Q4 2018

Jul 13, 2023
BUY
$33.0 - $60.04 $382,008 - $695,023
11,576 New
11,576 $417,000
Q4 2018

Feb 14, 2019
BUY
$33.0 - $60.04 $298,353 - $542,821
9,041 Added 356.65%
11,576 $418,000
Q3 2018

Jul 13, 2023
BUY
$56.15 - $73.9 $649,992 - $855,466
11,576 New
11,576 $713 Million
Q3 2018

Nov 14, 2018
SELL
$56.15 - $73.9 $507,652 - $668,129
-9,041 Reduced 78.1%
2,535 $156,000
Q2 2018

Aug 15, 2018
BUY
$47.85 - $70.45 $41,964 - $61,784
877 Added 8.2%
11,576 $0
Q1 2018

May 15, 2018
BUY
$51.15 - $61.0 $7,365 - $8,784
144 Added 1.36%
10,699 $0
Q4 2017

Feb 15, 2018
SELL
$50.85 - $65.1 $574,045 - $734,913
-11,289 Reduced 51.68%
10,555 $631,000
Q3 2017

Nov 14, 2017
BUY
$48.6 - $60.1 $54,577 - $67,492
1,123 Added 5.42%
21,844 $1.06 Million
Q2 2017

Aug 14, 2017
BUY
N/A
20,721
20,721 $1.09 Million

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email